 | • レポートコード：QYR9NV18087 • 出版社/出版日：QYResearch / 2019年11月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、レノックスガストー症候群治療の世界市場について調査・分析し、レノックスガストー症候群治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（非外科的治療、外科的治療）、用途別（発作、眼球異常、EEG所見、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のレノックスガストー症候群治療市場動向 ・主要企業別マーケットシェア ・レノックスガストー症候群治療の種類別市場規模2014-2019 （非外科的治療、外科的治療） ・レノックスガストー症候群治療の用途別市場規模2014-2019 （発作、眼球異常、EEG所見、その他） ・レノックスガストー症候群治療の北米市場：主要企業・種類別/用途別市場規模 ・レノックスガストー症候群治療のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・レノックスガストー症候群治療の中国市場：主要企業・種類別/用途別市場規模 ・レノックスガストー症候群治療の日本国内市場：主要企業・種類別/用途別市場規模 ・レノックスガストー症候群治療の東南アジア市場：主要企業・種類別/用途別市場規模 ・レノックスガストー症候群治療のインド市場：主要企業・種類別/用途別市場規模 ・レノックスガストー症候群治療の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Eisai Co., Ltd.、GlaxoSmithKline plc.、H. Lundbeck A/S、Johnson & Johnson Services, Inc.、Supernus Pharmaceuticals, Inc） ・レノックスガストー症候群治療の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Lennox–Gastaut syndrome (LGS) is a complex, rare, and severe childhood-onset epilepsy. It is characterized by multiple and concurrent seizure types, cognitive dysfunction, and slow spike waves on electroencephalogram (EEG). Typically, it presents in children aged 3–5 years and can persist into adulthood.Corpus callosotomy is a surgical procedure used for treating refractory generalized seizures caused due to Lennox-Gastaut syndrome (LGS). However, this surgical procedure involves craniotomy with microdissection. Therefore, companies are focusing on the development of minimally invasive procedures such as MR-guided laser interstitial thermal therapy (MRg-LITT). MRg-LITT has emerged as a safe, effective, and durable alternative of traditional open corpus callosotomy. The efficacy of MRg-LITT is also being tested in advanced surgical ablation of epileptogenic foci and corpus callosotomy. This will further boost its adoption in LGS treatment. Such advancements in surgical treatments will be one of the key trends that will impact LGS market growth in the coming years.
In 2018, the global Lennox-Gastaut Syndrome Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Lennox-Gastaut Syndrome Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Lennox-Gastaut Syndrome Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
Eisai Co., Ltd.
GlaxoSmithKline plc.
H. Lundbeck A/S
Johnson & Johnson Services, Inc.
Supernus Pharmaceuticals, Inc
…
Market segment by Type, the product can be split into
Non-surgical Treatment
Surgical Treatment
Market segment by Application, split into
Seizures
Ocular Abnormality
EEG Findings
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Lennox-Gastaut Syndrome Treatment status, future forecast, growth opportunity, key market and key players.
To present the Lennox-Gastaut Syndrome Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Lennox-Gastaut Syndrome Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Lennox-Gastaut Syndrome Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Non-surgical Treatment
1.4.3 Surgical Treatment
1.5 Market by Application
1.5.1 Global Lennox-Gastaut Syndrome Treatment Market Share by Application (2019-2025)
1.5.2 Seizures
1.5.3 Ocular Abnormality
1.5.4 EEG Findings
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Lennox-Gastaut Syndrome Treatment Market Size
2.2 Lennox-Gastaut Syndrome Treatment Growth Trends by Regions
2.2.1 Lennox-Gastaut Syndrome Treatment Market Size by Regions (2019-2025)
2.2.2 Lennox-Gastaut Syndrome Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
3.1 Lennox-Gastaut Syndrome Treatment Market Size by by Players
3.1.1 Global Lennox-Gastaut Syndrome Treatment Revenue by by Players (2014-2019)
3.1.2 Global Lennox-Gastaut Syndrome Treatment Revenue Market Share by by Players (2014-2019)
3.1.3 Global Lennox-Gastaut Syndrome Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Lennox-Gastaut Syndrome Treatment Key Players Head office and Area Served
3.3 Key Players Lennox-Gastaut Syndrome Treatment Product/Solution/Service
3.4 Date of Enter into Lennox-Gastaut Syndrome Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Lennox-Gastaut Syndrome Treatment Market Size by Type (2014-2019)
4.2 Global Lennox-Gastaut Syndrome Treatment Market Size by Application (2014-2019)
5 North America
5.1 North America Lennox-Gastaut Syndrome Treatment Market Size (2014-2019)
5.2 Lennox-Gastaut Syndrome Treatment Key Players in North America
5.3 North America Lennox-Gastaut Syndrome Treatment Market Size by Type
5.4 North America Lennox-Gastaut Syndrome Treatment Market Size by Application
6 Europe
6.1 Europe Lennox-Gastaut Syndrome Treatment Market Size (2014-2019)
6.2 Lennox-Gastaut Syndrome Treatment Key Players in Europe
6.3 Europe Lennox-Gastaut Syndrome Treatment Market Size by Type
6.4 Europe Lennox-Gastaut Syndrome Treatment Market Size by Application
7 China
7.1 China Lennox-Gastaut Syndrome Treatment Market Size (2014-2019)
7.2 Lennox-Gastaut Syndrome Treatment Key Players in China
7.3 China Lennox-Gastaut Syndrome Treatment Market Size by Type
7.4 China Lennox-Gastaut Syndrome Treatment Market Size by Application
8 Japan
8.1 Japan Lennox-Gastaut Syndrome Treatment Market Size (2014-2019)
8.2 Lennox-Gastaut Syndrome Treatment Key Players in Japan
8.3 Japan Lennox-Gastaut Syndrome Treatment Market Size by Type
8.4 Japan Lennox-Gastaut Syndrome Treatment Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Lennox-Gastaut Syndrome Treatment Market Size (2014-2019)
9.2 Lennox-Gastaut Syndrome Treatment Key Players in Southeast Asia
9.3 Southeast Asia Lennox-Gastaut Syndrome Treatment Market Size by Type
9.4 Southeast Asia Lennox-Gastaut Syndrome Treatment Market Size by Application
10 India
10.1 India Lennox-Gastaut Syndrome Treatment Market Size (2014-2019)
10.2 Lennox-Gastaut Syndrome Treatment Key Players in India
10.3 India Lennox-Gastaut Syndrome Treatment Market Size by Type
10.4 India Lennox-Gastaut Syndrome Treatment Market Size by Application
11 Central & South America
11.1 Central & South America Lennox-Gastaut Syndrome Treatment Market Size (2014-2019)
11.2 Lennox-Gastaut Syndrome Treatment Key Players in Central & South America
11.3 Central & South America Lennox-Gastaut Syndrome Treatment Market Size by Type
11.4 Central & South America Lennox-Gastaut Syndrome Treatment Market Size by Application
12 International Players Profiles
12.1 Eisai Co., Ltd.
12.1.1 Eisai Co., Ltd. Company Details
12.1.2 Company Description and Business Overview
12.1.3 Lennox-Gastaut Syndrome Treatment Introduction
12.1.4 Eisai Co., Ltd. Revenue in Lennox-Gastaut Syndrome Treatment Business (2014-2019))
12.1.5 Eisai Co., Ltd. Recent Development
12.2 GlaxoSmithKline plc.
12.2.1 GlaxoSmithKline plc. Company Details
12.2.2 Company Description and Business Overview
12.2.3 Lennox-Gastaut Syndrome Treatment Introduction
12.2.4 GlaxoSmithKline plc. Revenue in Lennox-Gastaut Syndrome Treatment Business (2014-2019)
12.2.5 GlaxoSmithKline plc. Recent Development
12.3 H. Lundbeck A/S
12.3.1 H. Lundbeck A/S Company Details
12.3.2 Company Description and Business Overview
12.3.3 Lennox-Gastaut Syndrome Treatment Introduction
12.3.4 H. Lundbeck A/S Revenue in Lennox-Gastaut Syndrome Treatment Business (2014-2019)
12.3.5 H. Lundbeck A/S Recent Development
12.4 Johnson & Johnson Services, Inc.
12.4.1 Johnson & Johnson Services, Inc. Company Details
12.4.2 Company Description and Business Overview
12.4.3 Lennox-Gastaut Syndrome Treatment Introduction
12.4.4 Johnson & Johnson Services, Inc. Revenue in Lennox-Gastaut Syndrome Treatment Business (2014-2019)
12.4.5 Johnson & Johnson Services, Inc. Recent Development
12.5 Supernus Pharmaceuticals, Inc
12.5.1 Supernus Pharmaceuticals, Inc Company Details
12.5.2 Company Description and Business Overview
12.5.3 Lennox-Gastaut Syndrome Treatment Introduction
12.5.4 Supernus Pharmaceuticals, Inc Revenue in Lennox-Gastaut Syndrome Treatment Business (2014-2019)
12.5.5 Supernus Pharmaceuticals, Inc Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Lennox-Gastaut Syndrome Treatment Key Market Segments
Table Key Players Lennox-Gastaut Syndrome Treatment Covered
Table Global Lennox-Gastaut Syndrome Treatment Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Non-surgical Treatment Figures
Table Key Players of Non-surgical Treatment
Figuer Surgical Treatment Figures
Table Key Players of Surgical Treatment
Table Global Lennox-Gastaut Syndrome Treatment Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Lennox-Gastaut Syndrome Treatment Market Share by Application in 2018 & 2025
Figure Seizures Case Studies
Figure Ocular Abnormality Case Studies
Figure EEG Findings Case Studies
Figure Others Case Studies
Figure Lennox-Gastaut Syndrome Treatment Report Years Considered
Figure Global Lennox-Gastaut Syndrome Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Lennox-Gastaut Syndrome Treatment Market Size by Regions 2019-2025 (Million US$)
Table Global Lennox-Gastaut Syndrome Treatment Market Size by Regions 2019-2025 (Million US$)
Table Global Lennox-Gastaut Syndrome Treatment Market Share by Regions 2014-2019
Figure Global Lennox-Gastaut Syndrome Treatment Market Share by Regions 2014-2019
Figure Global Lennox-Gastaut Syndrome Treatment Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Lennox-Gastaut Syndrome Treatment Revenue by by Players (2014-2019) (Million US$)
Table Global Lennox-Gastaut Syndrome Treatment Market Share by by Players (2014-2019)
Figure Global Lennox-Gastaut Syndrome Treatment Market Share by by Players in 2018
Table Global Lennox-Gastaut Syndrome Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Lennox-Gastaut Syndrome Treatment Product/Solution/Service
Table Date of Enter into Lennox-Gastaut Syndrome Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Lennox-Gastaut Syndrome Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Lennox-Gastaut Syndrome Treatment Market Size Share by Type (2014-2019)
Figure Global Lennox-Gastaut Syndrome Treatment Market Size Market Share by Type (2014-2019)
Table Global Lennox-Gastaut Syndrome Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Lennox-Gastaut Syndrome Treatment Market Size Share by Application (2014-2019)
Figure Global Lennox-Gastaut Syndrome Treatment Market Size Market Share by Application (2014-2019)
Figure Global Lennox-Gastaut Syndrome Treatment Revenue Market Share by Application in 2018
Figure North America Lennox-Gastaut Syndrome Treatment Market Size 2014-2019 (Million US$)
Table North America Key Players Lennox-Gastaut Syndrome Treatment Revenue (2018-2019) (Million US$)
Table North America Key Players Lennox-Gastaut Syndrome Treatment Market Share (2018-2019)
Table North America Lennox-Gastaut Syndrome Treatment Market Size by Type 2014-2019 (Million US$)
Table North America Lennox-Gastaut Syndrome Treatment Market Share by Type 2014-2019
Table North America Lennox-Gastaut Syndrome Treatment Market Size by Application 2014-2019 (Million US$)
Table North America Lennox-Gastaut Syndrome Treatment Market Share by Application 2014-2019
Figure Europe Lennox-Gastaut Syndrome Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Lennox-Gastaut Syndrome Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Lennox-Gastaut Syndrome Treatment Market Share (2018-2019)
Table Europe Lennox-Gastaut Syndrome Treatment Market Size by Type 2014-2019 (Million US$)
Table Europe Lennox-Gastaut Syndrome Treatment Market Share by Type 2014-2019
Table Europe Lennox-Gastaut Syndrome Treatment Market Size by Application 2014-2019 (Million US$)
Table Europe Lennox-Gastaut Syndrome Treatment Market Share by Application 2014-2019
Figure China Lennox-Gastaut Syndrome Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Lennox-Gastaut Syndrome Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Lennox-Gastaut Syndrome Treatment Market Share (2018-2019)
Table China Lennox-Gastaut Syndrome Treatment Market Size by Type 2014-2019 (Million US$)
Table China Lennox-Gastaut Syndrome Treatment Market Share by Type 2014-2019
Table China Lennox-Gastaut Syndrome Treatment Market Size by Application 2014-2019 (Million US$)
Table China Lennox-Gastaut Syndrome Treatment Market Share by Application 2014-2019
Figure Japan Lennox-Gastaut Syndrome Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Lennox-Gastaut Syndrome Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Lennox-Gastaut Syndrome Treatment Market Share (2018-2019)
Table Japan Lennox-Gastaut Syndrome Treatment Market Size by Type 2014-2019 (Million US$)
Table Japan Lennox-Gastaut Syndrome Treatment Market Share by Type 2014-2019
Table Japan Lennox-Gastaut Syndrome Treatment Market Size by Application 2014-2019 (Million US$)
Table Japan Lennox-Gastaut Syndrome Treatment Market Share by Application 2014-2019
Figure Southeast Asia Lennox-Gastaut Syndrome Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Lennox-Gastaut Syndrome Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Lennox-Gastaut Syndrome Treatment Market Share (2018-2019)
Table Southeast Asia Lennox-Gastaut Syndrome Treatment Market Size by Type 2014-2019 (Million US$)
Table Southeast Asia Lennox-Gastaut Syndrome Treatment Market Share by Type 2014-2019
Table Southeast Asia Lennox-Gastaut Syndrome Treatment Market Size by Application 2014-2019 (Million US$)
Table Southeast Asia Lennox-Gastaut Syndrome Treatment Market Share by Application 2014-2019
Figure India Lennox-Gastaut Syndrome Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Lennox-Gastaut Syndrome Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Lennox-Gastaut Syndrome Treatment Market Share (2018-2019)
Table India Lennox-Gastaut Syndrome Treatment Market Size by Type 2014-2019 (Million US$)
Table India Lennox-Gastaut Syndrome Treatment Market Share by Type 2014-2019
Table India Lennox-Gastaut Syndrome Treatment Market Size by Application 2014-2019 (Million US$)
Table India Lennox-Gastaut Syndrome Treatment Market Share by Application 2014-2019
Figure Central & South America Lennox-Gastaut Syndrome Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Lennox-Gastaut Syndrome Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Lennox-Gastaut Syndrome Treatment Market Share (2018-2019)
Table Central & South America Lennox-Gastaut Syndrome Treatment Market Size by Type 2014-2019 (Million US$)
Table Central & South America Lennox-Gastaut Syndrome Treatment Market Share by Type 2014-2019
Table Central & South America Lennox-Gastaut Syndrome Treatment Market Size by Application 2014-2019 (Million US$)
Table Central & South America Lennox-Gastaut Syndrome Treatment Market Share by Application 2014-2019
Table Eisai Co., Ltd. Company Details
Table Eisai Co., Ltd. Revenue in Lennox-Gastaut Syndrome Treatment Business 2014-2019 (Million US$)
Figure Eisai Co., Ltd. Revenue Growth Rate in Lennox-Gastaut Syndrome Treatment Business (2014-2019)
Table Eisai Co., Ltd. Recent Development
Table GlaxoSmithKline plc. Company Details
Table GlaxoSmithKline plc. Revenue in Lennox-Gastaut Syndrome Treatment Business 2014-2019 (Million US$)
Figure GlaxoSmithKline plc. Revenue Growth Rate in Lennox-Gastaut Syndrome Treatment Business (2014-2019)
Table GlaxoSmithKline plc. Recent Development
Table H. Lundbeck A/S Company Details
Table H. Lundbeck A/S Revenue in Lennox-Gastaut Syndrome Treatment Business 2014-2019 (Million US$)
Figure H. Lundbeck A/S Revenue Growth Rate in Lennox-Gastaut Syndrome Treatment Business (2014-2019)
Table H. Lundbeck A/S Recent Development
Table Johnson & Johnson Services, Inc. Company Details
Table Johnson & Johnson Services, Inc. Revenue in Lennox-Gastaut Syndrome Treatment Business 2014-2019 (Million US$)
Figure Johnson & Johnson Services, Inc. Revenue Growth Rate in Lennox-Gastaut Syndrome Treatment Business (2014-2019)
Table Johnson & Johnson Services, Inc. Recent Development
Table Supernus Pharmaceuticals, Inc Company Details
Table Supernus Pharmaceuticals, Inc Revenue in Lennox-Gastaut Syndrome Treatment Business 2014-2019 (Million US$)
Figure Supernus Pharmaceuticals, Inc Revenue Growth Rate in Lennox-Gastaut Syndrome Treatment Business (2014-2019)
Table Supernus Pharmaceuticals, Inc Recent Development
Table Global Lennox-Gastaut Syndrome Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Lennox-Gastaut Syndrome Treatment Market Size Share by Regions (2019-2025)
Figure Global Lennox-Gastaut Syndrome Treatment Market Size Share by Regions in 2025
Figure North America Lennox-Gastaut Syndrome Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Lennox-Gastaut Syndrome Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Lennox-Gastaut Syndrome Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Lennox-Gastaut Syndrome Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Lennox-Gastaut Syndrome Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Lennox-Gastaut Syndrome Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Lennox-Gastaut Syndrome Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Lennox-Gastaut Syndrome Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Lennox-Gastaut Syndrome Treatment Market Size by Product (2019-2025)
Figure Global Lennox-Gastaut Syndrome Treatment Market Size by Product in 2025
Table Global Lennox-Gastaut Syndrome Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Lennox-Gastaut Syndrome Treatment Market Size by Application (2019-2025)
Figure Global Lennox-Gastaut Syndrome Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
レノックスガストー症候群治療のグローバル市場：規模・現状・予測2019-2025 Lennox–Gastaut syndrome (LGS) is a complex, rare, and severe childhood-onset epilepsy. It is characterized by multiple and concurrent seizure types, cognitive dysfunction, and slow spike waves on electroencephalogram (EEG). Typically, it presents in children aged 3–5 years and can persist into adult…- レノックスガストー症候群治療のグローバル市場：規模・現状・予測2019-2025 Lennox–Gastaut syndrome (LGS) is a complex, rare, and severe childhood-onset epilepsy. It is characterized by multiple and concurrent seizure types, cognitive dysfunction, and slow spike waves on electroencephalogram (EEG). Typically, it presents in children aged 3–5 years and can persist into adult…
- HIV関連リポジストロフィー症候群治療のグローバル市場：規模・現状・予測2019-2025 Lipodystrophy syndrome groups together three clinical conditions characterized by abnormal body fat distribution: lipoatrophy, lipoaccumulation and a mixed syndrome. In 2018, the global HIV Associated Lipodystrophy Syndrome Treatment market size was xx million US$ and it is expected to reach xx mill…
- HIV関連リポジストロフィー症候群治療のグローバル市場：規模・現状・予測2019-2025 Lipodystrophy syndrome groups together three clinical conditions characterized by abnormal body fat distribution: lipoatrophy, lipoaccumulation and a mixed syndrome. In 2018, the global HIV Associated Lipodystrophy Syndrome Treatment market size was xx million US$ and it is expected to reach xx mill…
- HIV関連リポジストロフィー症候群治療のグローバル市場：規模・現状・予測2019-2025 Lipodystrophy syndrome groups together three clinical conditions characterized by abnormal body fat distribution: lipoatrophy, lipoaccumulation and a mixed syndrome. In 2018, the global HIV Associated Lipodystrophy Syndrome Treatment market size was xx million US$ and it is expected to reach xx mill…